Tech Company Financing Transactions

TMRW Life Sciences Funding Round

On 7/21/2021, TMRW Life Sciences raised $105 million in Series C investment from Transformation Capital, 5AM Ventures and Casdin Capital.

Transaction Overview

Company Name
TMRW Life Sciences
Announced On
7/21/2021
Transaction Type
Debt
Venture Equity
Amount
$105,000,000
Round
Series C
Investors

Transformation Capital (Lead Investor)

5AM Ventures

Casdin Capital

GV

private investors (Anne Wojcicki)

private investors (Peter Thiel)

private investors (Susan Wojcicki)

LSI

Proceeds Purpose
The company intends to use the funds to accelerate global expansion, advance product innovation, develop consumer awareness of the platform, and support future business development opportunities.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
250 Hudson St. 701
New York, NY 10013
USA
Phone
(917) 525-3453
Website
www.tmrw.org
Email Address
[email protected]
Overview
TMRW is revolutionizing in vitro fertilization with the first automated and robotic cryo-management platform devoted to IVF. TMRW's cryo-management platform features 100% physical and digital chain-of-custody and continuous local and remote monitoring.
Profile
TMRW Life Sciences LinkedIn Company Profile
Social Media
TMRW Life Sciences Company Twitter Account
Company News
TMRW Life Sciences News
Facebook
TMRW Life Sciences on Facebook
YouTube
TMRW Life Sciences on YouTube

Management Team

Title
Name
Email & Social
Chairman
Alan Murray
  Alan Murray LinkedIn Profile  Alan Murray Twitter Account  Alan Murray News  Alan Murray on Facebook
Chief Executive Officer
Joshua Abram
  Joshua Abram LinkedIn Profile  Joshua Abram Twitter Account  Joshua Abram News  Joshua Abram on Facebook
Chief Information Officer
Amit Gupta
  Amit Gupta LinkedIn Profile  Amit Gupta Twitter Account  Amit Gupta News  Amit Gupta on Facebook
Chief Medical Officer
Jeffrey Port
  Jeffrey Port LinkedIn Profile  Jeffrey Port Twitter Account  Jeffrey Port News  Jeffrey Port on Facebook
Chief Operating Officer
William Garbarini
  William Garbarini LinkedIn Profile  William Garbarini Twitter Account  William Garbarini News  William Garbarini on Facebook
Chief Operating Officer
Melanie Goldey
  Melanie Goldey LinkedIn Profile  Melanie Goldey Twitter Account  Melanie Goldey News  Melanie Goldey on Facebook
VP - Bus. Development
Lori Batta
  Lori Batta LinkedIn Profile  Lori Batta Twitter Account  Lori Batta News  Lori Batta on Facebook
VP - Engineering
Christina Raad
  Christina Raad LinkedIn Profile  Christina Raad Twitter Account  Christina Raad News  Christina Raad on Facebook
VP - Finance
Lexi Henkel
  Lexi Henkel LinkedIn Profile  Lexi Henkel Twitter Account  Lexi Henkel News  Lexi Henkel on Facebook
VP - Product Management
Benjamin Harlow
  Benjamin Harlow LinkedIn Profile  Benjamin Harlow Twitter Account  Benjamin Harlow News  Benjamin Harlow on Facebook
VP - Regulatory Affairs
Michael Collins
  Michael Collins LinkedIn Profile  Michael Collins Twitter Account  Michael Collins News  Michael Collins on Facebook

 

 

Browse more venture capital transactions:

Prev: 7/21/2021: Sundae venture capital transaction
Next: 7/21/2021: Ancora Heart venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.